Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06248229 · ClinicalTrials.gov registry record · Phase 4
A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD).
A Phase 4 study of Fatigue and Attention Deficit Hyperactivity Disorder, sponsored by Rochester Center for Behavioral Medicine.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06248229 is a Phase 4 study of Fatigue and Attention Deficit Hyperactivity Disorder that is actively recruiting participants, run by Rochester Center for Behavioral Medicine. The registered enrollment target is 50 participants, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06248229, a Phase 4 study of Fatigue and Attention Deficit Hyperactivity Disorder, is actively recruiting participants, sponsored by Rochester Center for Behavioral Medicine.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to study the impact of Dyanavel on co-occuring fatigue in adults with Attention Deficit/Hyperactivity Disorder. The main question it aims to answer is whether Dyanavel XR leads to a statistically significant reduction in fatigue compared to placebo, as measured by the Fatigue Symptom Inventory.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Dyanavel XR
Study Locations (1)
Michigan
- Rochester Center for Behavioral Medicine - Rochester Hills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-09-01 |
| Est. Completion | 2026-12-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06248229
The ClinicalTrials.gov registry entry for NCT06248229 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (77% lower). The listed sponsor is Rochester Center for Behavioral Medicine, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Fatigue appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06248229 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT06248229 about?
NCT06248229 is a clinical study titled "A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD).". The goal of this clinical trial is to study the impact of Dyanavel on co-occuring fatigue in adults with Attention Deficit/Hyperactivity Disorder. The main question it aims to answer is whether Dyanavel XR leads to a statistically significant reduction in fatigue compared to placebo, as measured by ...
What is the current status of trial NCT06248229?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2024-09-01. Estimated completion is 2026-12-01.
What conditions does trial NCT06248229 study?
This clinical trial studies the following conditions: Fatigue, Attention Deficit Hyperactivity Disorder, Attention Deficit Disorder.
What interventions are being tested in trial NCT06248229?
The interventions under investigation include: Placebo (DRUG), Dyanavel XR (DRUG).
Who is sponsoring clinical trial NCT06248229?
This trial is sponsored by Rochester Center for Behavioral Medicine, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06248229 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fatigue
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors
RECRUITING · Phase 4
-
Fatigue and Cognitive Demand With Aging
RECRUITING · NA
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
-
Behavioral and Neural Correlates of Post-Stroke Fatigue
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
-
Eccentric Exercise and Fatigue in Multiple Sclerosis
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.